Theratechnologies Kurs / Umsatz
Was ist das Kurs / Umsatz von Theratechnologies?
Kurs / Umsatz von Theratechnologies Inc. ist 1.20
Was ist die Definition von Kurs / Umsatz?
Das Kurs-Umsatz-Verhältnis ist der Aktienkurs eines Unternehmens im Vergleich zu seinen Einnahmen.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Kurs / Umsatz von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Theratechnologies
Was macht Theratechnologies?
theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.
Unternehmen mit kurs / umsatz ähnlich Theratechnologies
- Vulcan Steel Ltd hat Kurs / Umsatz von 1.20
- Clifford Modern Living hat Kurs / Umsatz von 1.20
- Bhageria Industries hat Kurs / Umsatz von 1.20
- Hind Rectifiers hat Kurs / Umsatz von 1.20
- Top Spring International hat Kurs / Umsatz von 1.20
- Changsha Broad Homes Industrial Co hat Kurs / Umsatz von 1.20
- Theratechnologies hat Kurs / Umsatz von 1.20
- Qinqin Foodstuffs (Cayman) hat Kurs / Umsatz von 1.20
- Acusphere hat Kurs / Umsatz von 1.20
- TCPL Packaging hat Kurs / Umsatz von 1.20
- Total Gabon hat Kurs / Umsatz von 1.20
- USD Partners LP hat Kurs / Umsatz von 1.20
- Wuhan Bester Telecom Co hat Kurs / Umsatz von 1.20